Streetbeat News

Price Targets

PAYO

In the past three months, 7 analysts have rated Payoneer Global (NASDAQ:PAYO), with most being bullish. The average 12-month price target increased by 12.61% to $8.93. Analysts have raised their ratings and price targets, reflecting positive sentiment. Despite positive revenue growth, Payoneer faces challenges with net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:00 pm

WEST

Truist Securities has initiated coverage on Westrock Coffee with a Buy rating and set a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:58 am

DPZ

Piper Sandler analyst Brian Mullan maintains a Neutral rating on Domino's Pizza (NYSE:DPZ) and lowers the price target from $436 to $429.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:56 am

NFLX

Piper Sandler has upgraded Netflix's stock rating from Neutral to Overweight and increased its price target from $650 to $800, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:52 am

IMTX

Piper Sandler has initiated coverage on Immatics (NASDAQ:IMTX) with an Overweight rating and set a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:49 am

SOLV

Piper Sandler has initiated coverage on Solventum (NYSE:SOLV) with a Neutral rating and set a price target of $71.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:47 am

DPZ

Evercore ISI Group has maintained an 'Outperform' rating on Domino's Pizza but lowered its price target from $500 to $480.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:44 am

CRL

Evercore ISI Group has downgraded Charles River Laboratories (NYSE:CRL) from Outperform to In-Line and reduced the price target from $225 to $190.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:41 am

CON

B of A Securities has downgraded Concentra Group Holdings from Buy to Neutral and lowered its price target from $30.5 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:38 am

USPH

B of A Securities has downgraded US Physical Therapy (NYSE:USPH) from Buy to Neutral and reduced the price target from $114 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:35 am